FREQUENTLY Asked Questions
What should you consider for research controls in an animal study?
View All FAQs
About the Author
Proxima CRO Team
Isabella Schmitt, RAC
Director of Regulatory Affairs

Prior to joining Proxima, Isabella served as the Senior Regulatory & Quality Manager at a medical device company, where she outlined the regulatory strategy & put together design controls & design history documentation. She was the Dir. of CMC & Quality at a biopharmaceutical company, where she oversaw all manufacturing and analytical processes and timelines and ensured CMC regulatory strategy was sufficient for filings in Europe and the US.

Evaluation of device safety is often based on animal studies that provide valid scientific evidence (21 CFR 860.7(d)), and whether or not a facility has adequate standard operating procedures to ensure the quality and integrity of the data (21 CFR 58.81). FDA recommends that animal studies include adequate controls to minimize experimental variability and error. Such research controls include, but are not limited to, the minimization of anything given to or affecting the test animal in the course of an experiment that would impact the comparison between the test animals (i.e. animals receiving the test article) and control animals (i.e. animals receiving the control article). Variables that may impart change to the test animals may be devices other than the test article, or they may consist of background factors such as environmental factors, concomitant medications, or co-morbidities. You should minimize these confounding factors because they may hinder the ability of the investigator and FDA to clearly associate adverse or positive outcomes with the device and/or its effects.

Related Terms:
No items found.
Related FAQs:
More Questions? We're here to help!
SPEAK WITH A SPECIALIST